StockWatch
·
MANORAMA · Q2 FY27 · PREVIEW

Can margins hold? Q2 test after customs-duty hit

Manorama's Q1 momentum — 39.5% revenue growth, 67.5% profit jump — set a high bar. Q2 must prove the specialty-fats surge wasn't a blip, and margins can stay robust after August's ₹20.64 Cr customs outflow.

Q2 FY27 resultsMANORAMAManorama Industries Ltd09 Nov 2026 · 3 min read

The setup: Manorama shattered the ₹400 Cr quarterly ceiling in Q1 FY27 — revenue ₹404.0 Cr, up 39.5% YoY, and consolidated PAT leapt 67.5% to ₹78.7 Cr. The stock rallied 8% on the news, and the Street's median target (₹2,003) sits 25.9% above the current ₹1,957.8 (as of Nov 6). But Q2 is the real test: can the company hold margins after a ₹20.64 Cr customs duty hit in August, and does the specialty-fats boom stick as demand normalizes?

Q2 revenue expectation

~₹390 Cr

On-plan pace; Q1 ₹404 Cr sets high bar; seasonal Q2 softness typical in edible oils

EBITDA margin

25–27%

Company guidance; Q1 ran at 26.8%; watch for commodity cost pass-through

PAT expectation

~₹65–75 Cr

Q1 consolidated PAT ₹78.7 Cr; normalize for seasonal mix & no outsized items

FY27 full-year guidance

₹1,670 Cr revenue

+22.1% YoY; implies Q3–Q4 slower than H1; reaffirmation critical

What strong vs weak looks like: STRONG: Q2 revenue ₹400+ Cr (holds the ₹400 Cr run-rate; specialty-fats demand intact); EBITDA margin 26%+ (shows cost control despite customs hit); cash flow robust; any guidance uplift for FY27; West Africa expansion tracking. Market re-rates on execution confidence. WEAK: Q2 revenue <₹370 Cr (reversal to pre-Q1 trends; volume rollover or pricing pressure); EBITDA margin <25% (margin compression post-duty; input costs bite harder); FY27 guidance lowered or flat; West Africa capex drag shows up. Stock sentiment swings to "growth was one-quarter wonder."

On track? Manorama committed to FY27 revenue growth of +22.1% YoY (₹1,670 Cr). H1 implies ~₹800 Cr run (Q1 ₹404 + Q2 ~₹390), which puts them on track for a ₹1,670 Cr full year — assuming Q3–Q4 compounds at a steady pace. The real question is margin: Q1's 26.8% EBITDA margin is above the 25–27% guided range. If Q2 holds 25%+, the company has proven the customs hit was a one-time cash drain, not an operational reset. If margins slip <25%, Street consensus (which prices 27% EBITDA margin into targets) will reset lower.

Three things to watch on result day (Nov 12)
  • 1 · Margin hold post-customs

    Did the ₹20.64 Cr duty payment (Aug) leave a lasting scar? Watch EBITDA margin: if Q2 is 25%+, the hit was cash-only (already absorbed); if <25%, input-cost pressure or input-mix erosion is real. This is the margin call for FY27 guidance credibility.

  • 2 · Seasonality & volumes

    Q2 typically softer than Q1 in edible oils (post-harvest, inventory normalization). Q2 <₹370 Cr would signal either volume rollover (demand weakness) or pricing pullback (commodity pressure). Q2 ≥₹390 Cr keeps the growth narrative alive. Revenue commentary will matter as much as the number.

  • 3 · FY27 guide reaffirmation

    Will the company reaffirm ₹1,670 Cr FY27 revenue (or adjust)? If they upgrade, Street will re-rate. If they downgrade or narrow range, expect selling on the release (Q1 was the peak; Q3–Q4 slower). Management tone on specialty-fats demand and West Africa capex spend will signal confidence or caution.

Since last quarter: filings scan

Material filings post-Q1 (Aug 13 – Nov 6, 2026)

Aug 10, 2026

Event

Customs duty settlement: ₹20.64 Cr paid (differential duty, IGST, penalty on imported Palm Mid Fraction eligibility dispute)

Operational flag?

Cash headwind absorbed; likely behind them. No ongoing regulatory risk disclosed.

Aug 11, 2026

Event

BSE clarification on customs inquiry disclosure delay

Operational flag?

Routine compliance filing; no new operational risk.

Sep 4, 2026

Event

Board approves Dr. Rohini Tiwari as Independent Director; director appointment & subsidiary capex increases approved

Operational flag?

Routine governance. Subsidiary capex increases signal West Africa expansion capex continues (as guided).

Sep 22, 2026

Event

Board approves share capital increase for three wholly-owned subsidiaries (Benin, Chad, Burkina Faso)

Operational flag?

West Africa expansion on track. Capex allocation tracking to guidance.

Sep 26, 2026

Event

Trading window closes for Q2 FY27 results

Operational flag?

Routine; signals board confidence ahead of earnings.

Aug 27, 2026

Event

FY26 Annual Report filed; AGM scheduled Sep 21, 2026

Operational flag?

Routine annual governance; no new disclosures on FY27 guidance.

Nov 4, 2026

Event

Board meeting intimation: Nov 12, 2026 board to approve Q2 FY27 (unaudited) results

Operational flag?

On schedule; result announcement imminent.

Summary: The customs duty is behind them; no other material regulatory risk flagged. West Africa capex is progressing (subsidiary share-capital increases in Sep confirm ongoing investment in Benin, Chad, Burkina Faso). Insider trading window closure suggests management confidence. Bulk deals in Aug (Microcurves Trading microcap rotation, not promoter-linked) were routine and non-material.

The narrative: Manorama Industries breached the ₹400 Cr quarterly mark in Q1 FY27 on the back of specialty-fats demand and strong operating execution. The customs duty outflow (₹20.64 Cr) was a one-quarter cash hit. Q2 is the proof: does revenue hold near ₹400 Cr, do margins stay 25%+, and will management reaffirm full-year guidance? The Street is constructive (₹2,003 median target, +25.9% upside), but the stock is pricing execution. A revenue beat or margin upside, paired with FY27 guide reaffirmation, re-rates the stock. A miss on either front (Q2 <₹370 Cr or margin <25%) risks 5–8% correction.

On result day (Nov 12): Focus on three things — (1) Q2 revenue & margin post-customs, (2) seasonality narrative (are we normalizing or demand-soft?), and (3) FY27 full-year guide (reaffirm, upgrade, or caution?). The fundamentals are sound; the debate is execution pace and consistency.

Informational and educational content only. Not investment advice.